✦ LIBER ✦

Novel cell therapy for type 1 diabetes mellitus

✍ Scribed by Friedrich C. Luft

Book ID: 105796830
Publisher: Springer
Year: 2009
Tongue: English
Weight: 83 KB
Volume: 87
Category: Article
ISSN: 0946-2716
DOI: 10.1007/s00109-009-0476-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incretin therapy for type 2 diabetes mel

Incretin therapy for type 2 diabetes mellitus

✍ David C. Klonoff 📂 Article 📅 2010 🏛 Springer Healthcare Communications 🌐 English ⚖ 291 KB

T-cell autoimmunity in type 1 diabetes m

T-cell autoimmunity in type 1 diabetes mellitus

✍ Ohad S. Birk; Irun R. Cohen 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 890 KB

Insulin dependent diabetes mellitus is a T-cell mediated autoimmune disease. Several &cell antigens, mostly non-tissue-specific, have been implicated in the disease process. The antigens and the autoimmune T cells exist in healthy individuals, as do many of the genes required for the development of

Insulin analogues: New therapies for typ

Insulin analogues: New therapies for type 2 diabetes mellitus

✍ M. Angelyn Bethel; Mark N. Feinglos 📂 Article 📅 2002 🏛 Current Science Inc. 🌐 English ⚖ 316 KB

Diabetes mellitus type 2: pathogenese en

Diabetes mellitus type 2: pathogenese en therapie

✍ P. L. B. Bruijnzeel 📂 Article 📅 2005 🏛 Prelum Uitgevers ⚖ 61 KB

Transient neonatal diabetes mellitus typ

Transient neonatal diabetes mellitus type 1

✍ Deborah J.G. Mackay; I. Karen Temple 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Managing diabetes: lessons from Type 1 d

Managing diabetes: lessons from Type 1 diabetes mellitus

✍ Philip E. Cryer 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Glycaemic control is a key component of the successful management of Type 1 and Type 2 diabetes mellitus. Hypoglycaemia is the limiting factor in the management of diabetes because current glucose-lowering regimens are imperfect, defences against decreasing glucose levels in Type 1 and probably Type